Previously, we found the acute therapeutic application of S100B at nanomolar concentrations to promote hippocampal progenitor cell proliferation, differentiation, and migration [11], and to improve the functional hippocampal-dependent outcome after experimental brain injury in rats [15]. The gene discussed is S100B; the disease is injury.